Asia
Another pandemic may be building in China. This time, it’s a new strain of the H1N1 swine flu and it’s already jumped to humans.
Amidst the pandemic, the biopharma industry continues to surge ahead. Jobs look plentiful. Check out these companies that have made recent job announcement expansions.
Cambridge, Massachusetts-based Carmine Therapeutics inked a research collaboration deal with Japan’s Takeda Pharmaceutical to develop and commercialize non-viral gene therapies for two rare diseases.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 1, 2020.
Biopharma and life sciences companies bolster their executive teams and board with these Movers & Shakers.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The companies will work to discover, develop and commercialize novel therapies that modulate G protein-coupled receptor (GPCR) targets that AbbVie selects.
Biopharma and life sciences companies provide updates on their pipelines and business plans.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 24, 2020.
The diagnostic tool will use Thermo Fisher’s next-generation sequencing (NGS)-based Oncomine Dx Target Test to identify HER2 (human epidermal growth factor receptor 2) gene mutations.
PRESS RELEASES